Advances toward developing more sensitive imaging techniques for diagnosing metastatic PCa include positron emission tomography combined with computed tomography (PET/CT) using, for example, prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals or [18F]fluoride. Here, FOLH1 is linked to posterior cortical atrophy.